Investment consortium acquires Nestlé Skin Health for €9.35bn, rebrands as Galderma

By Kacey Culliney

- Last updated on GMT

The newly-rebranded Galderma will be purely focused on dermatology - a 'highly attractive' growth sector (Getty Images)
The newly-rebranded Galderma will be purely focused on dermatology - a 'highly attractive' growth sector (Getty Images)

Related tags Nestlé skin health Galderma Nestlé Dermatology acquisition

A consortium of renowned institutional investors has acquired Nestlé Skin Health, rebranding the entire unit Galderma and refocusing it as a pure play dermatology business.

The move makes newly-branded Galderma the largest independent global dermatology company in the world.

Renowned institutional investors

The consortium behind the acquisition is made up of renowned institutional investors, including Swedish equity firm EQT, Canadian pension fund managers PSP Investments and wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA) Luxinva.

Nestlé first entered into negotiations to sell-off its Nestlé Skin Health business back in May. The CHF 10.2bn (€9.35bn) transaction has now been completed following necessary approvals.

Nestlé Skin Health pulled in net sales of €2.5bn (CHF 2.8bn) in 2018 across its three units – prescription, aesthetics and consumer care – all set to be kept under the acquisition but re-focused on pureplay dermatology.

‘Highly attractive dermatology sector’

The consortium said Galderma would now be led into its next phase of growth and innovation by an “experienced management team and board”.

Dr. Flemming Ornskov had been appointed CEO, following executive positions at Shire and Bayer, and Thomas Dittrich (previously Shire and Amgen) appointed CFO.

Ornskov said the management and team at Nestlé Skin Health had done an “excellent job creating a high-growth, leading dermatology business”​.

“I believe that Galderma, as a newly focused pureplay dermatology business, has outstanding prospects built on its existing quality portfolio, team and rich pipeline of innovation. I look forward to working with the talented Galderma team to further build on its success to date,”​ the new CEO said.

Nestlé Skin Health’s outgoing CEO Stuart Raetzman joined Galderma’s Advisory Board as a director, alongside Sheri McCoy (ex-Avon Products and Johnson & Johnson). The Board would be led by chairman Thomas Ebeling, former CEO of Novartis Pharma, Novartis Consumer Health and ProSiebenSat1Media.

The Galderma consortium said all appointed executives had “proven track records”​ in building sustainable and high-growth businesses in pharmaceutical and consumer industries.

International expansion, US & China focus

Galderma said it would continue to invest in innovation and commercial development, with a clear focus on international expansion.

“The new owners intend to advance the current direction taken by Galderma’s management and focus on accelerating growth further by building on the company’s leading market positions and brands in a sector benefiting from strong innovation and demographic trends.”

In particular, the company would continue to increase presence in the US and China.

Galderma would keep its headquarters in Switzerland.

Related news

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 11-Jun-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 23-Feb-2024 | Sponsored Link

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

Give collagen and your products a boost

Give collagen and your products a boost

Content provided by Lycored SARL | 14-Feb-2024 | White Paper

Lumenato, Lycored’s scientifically supported proprietary wellness extract, gets to work quickly complementing and protecting the structural benefits of...

Follow us


View more



Beauty 4.0 Podcast